Comprehensive Review of Diarrhea

Definitions

• Acute diarrhea: typically >3 loose or watery stools per day with duration <4 weeks (pediatric sources sometimes use <4 weeks for acute and >2–4 weeks to define chronic).
• Chronic diarrhea: diarrhea lasting >4 weeks (some pediatric references cite >2–4 weeks).

Epidemiology and Context

Diarrhea is a leading cause of mortality in children <5 years worldwide; infectious etiologies such as rotavirus are major contributors.

Normal stool output on a Western diet: approximately 10 mL/kg/day in infants and ~200 g/day in adults. Infants may pass stool multiple times daily or once every two weeks and still be within normal limits for growth and development.

Pathophysiologic Classifications

Osmotic Diarrhea

• Mechanism: unabsorbed solutes draw water into the lumen (e.g., carbohydrate malabsorption, celiac disease, pancreatic disease).
• Key feature: improves with fasting.
• Stool osmotic gap: typically >125 mOsm/kg.

Secretory Diarrhea

• Mechanism: active electrolyte and water secretion or failure of absorption (e.g., cholera, hormone-secreting tumors).
• Key feature: persists with fasting and during sleep.
• Stool osmotic gap: typically <50 mOsm/kg.
• Stool osmotic gap formula (approximate): Stool Osmotic Gap = 290 − 2 × (Stool Na + Stool K) mOsm/kg.

Inflammatory Diarrhea

• Mechanism: mucosal injury and inflammation with cytokine/prostaglandin-mediated secretion, exudation and impaired absorption.
• Typical causes: invasive bacteria, inflammatory bowel disease, ischemic or radiation injury.
• Key features: fever, bloody stools, fecal leukocytes, raised fecal calprotectin.

Mixed and Other Mechanisms

Many etiologies show overlapping mechanisms or evolve from one pattern to another; thorough evaluation often necessary to identify dominant processes.

Clinical Evaluation

History

• Duration and onset (acute vs chronic vs recurrent).
• Number of stools per day, stool volume and consistency (large-volume usually small intestinal; small-volume usually colonic).
• Presence of blood, painful defecation, fecal urgency.
• Diarrhea during fasting or sleep suggests secretory cause.
• Associated symptoms: fever, vomiting, abdominal pain, rash, joint symptoms.
• Dietary history: fruit juice, milk, sorbitol/fructose intake, carbohydrate load.
• Recent antibiotic use, travel, sick contacts, camping, or food exposures.
• Surgical history (bowel resection, short bowel), family history (CF, IBD), immunodeficiency risks.
• Growth, weight loss, failure to thrive, extraintestinal features (uveitis, aphthous ulcers, arthritis) suggest inflammatory or systemic disease.

Physical Examination

• Assess hydration: general appearance, mucous membranes, capillary refill, heart rate, respiratory rate, urine output, orthostatic signs.
• Measure current and premorbid weight and plot growth chart.
• Abdominal exam: tenderness, distension, masses.
• Perianal/rectal exam: fissures, skin tags, fistulae.
• Extraintestinal signs: pallor, jaundice, rash, joint findings, hepatosplenomegaly, signs of fat-soluble vitamin deficiency.

Diagnostic Testing

Stool Tests

• Stool pH and reducing substances (suggest carbohydrate malabsorption when acidic with reducing substances).
• Stool electrolytes and stool osmotic gap to differentiate secretory vs osmotic diarrhea.
• Fecal leukocytes, lactoferrin, fecal calprotectin (markers of inflammation).
• Occult blood testing.
• Quantitative/qualitative 3-day fecal fat for steatorrhea (gold standard though cumbersome).
• Stool ova & parasites; stool cultures; testing for C. difficile toxin where indicated.
• Fecal pancreatic elastase (exocrine pancreatic insufficiency).
• Stool alpha-1 antitrypsin (protein-losing enteropathy).

Blood and Systemic Tests

• CBC, ESR, CRP for inflammation or infection.
• Serum albumin and total protein for nutritional status and protein loss.
• Liver tests (bilirubin, ALT, AST, GGT) and serum bile acids when cholestasis or bile acid malabsorption suspected.
• Thyroid function (TSH, free T4) when hyperthyroidism suspected.
• Celiac panel: total IgA, anti-tissue transglutaminase IgA, anti-endomysial IgA.
• Fat soluble vitamin levels (A, D, E, K) and B12/folate when malabsorption suspected.

Other Diagnostic Modalities

• Breath hydrogen testing for lactose and fructose malabsorption.
• Sweat chloride testing for cystic fibrosis.
• Imaging: abdominal radiograph (KUB), small bowel follow-through, MR enterography or CT enterography for structural/small bowel disease.
• Endoscopy: EGD with duodenal biopsies, colonoscopy with biopsies, and video capsule endoscopy when indicated.

Differential Diagnosis Overview

Acute Diarrhea (common causes)

• Viral gastroenteritis: rotavirus, norovirus, calicivirus, enterovirus, astrovirus.
• Bacterial: Salmonella, Campylobacter, E. coli, Shigella, Yersinia, Vibrio cholerae, Aeromonas, Clostridioides difficile.
• Parasitic: Giardia, Entamoeba histolytica, Cryptosporidium, Isospora, Strongyloides.
• Drug-induced: antibiotics, laxatives, magnesium-containing antacids, opiate withdrawal.
• Extraintestinal infections and surgical causes: sepsis, UTI, respiratory infections, appendicitis, intussusception.

Chronic Diarrhea (major categories)

• Malabsorptive disorders: carbohydrate, fat, and protein malabsorption.
• Inflammatory: IBD (Crohn, ulcerative), celiac disease, microscopic/collagenous colitis, eosinophilic gastroenteritis.
• Congenital diarrheal disorders: microvillus inclusion disease, tufting enteropathy, congenital chloride/sodium channel diarrheas, congenital glucose-galactose malabsorption, sucrase-isomaltase deficiency, congenital lactase deficiency, enterokinase deficiency.
• Intestinal failure and short bowel syndrome secondary to resection or motility disorders.
• Chronic infections: persistent parasitic infections, HIV-associated enteropathy, chronic C. difficile.
• Medication-induced chronic diarrhea: chronic laxative abuse, long-term antibiotics, magnesium antacids.
• Neuroendocrine tumors and secretory syndromes: VIPoma, gastrinoma, carcinoid, etc.
• Functional and overflow etiologies: IBS and fecal impaction with overflow.

Selected Specific Disorders and Management Points

Antibiotic-Associated Diarrhea (AAD)

• Definition: unexplained diarrhea of ≥3 soft/liquid stools for ≥2 consecutive days occurring between 2 hours and 2 months after starting antibiotics.
• Prevalence: occurs in ~11–21% of children exposed to antibiotics, typically starting ~5 days after initiation and lasting ~4 days on average.
• Common antibiotics implicated: amoxicillin-clavulanate and erythromycin.
• C. difficile accounts for roughly 20% of AAD cases.
• Treatment: discontinue or change offending antibiotic when feasible; treat C. difficile per severity (oral metronidazole or oral vancomycin per current guidance); avoid antimotility agents in toxin-mediated colitis.
• Prevention: probiotics such as Saccharomyces boulardii and Lactobacillus rhamnosus GG reduce AAD incidence in children and lower C. difficile risk.

Chronic Nonspecific Diarrhea of Childhood (Toddler Diarrhea)

• Definition: stool volume >10 mL/kg/day in infants/toddlers or >200 mL/day in older children for >14 days with normal growth and no red flags.
• Typical age: 6 months to 5 years; stools more watery later in the day.
• Causes: low-fat diet, high simple carbohydrate intake (fructose/sorbitol), accelerated small-bowel transit (prostaglandin-mediated).
• Management: dietary modification (reduce simple carbohydrates, increase fat within age-appropriate limits); loperamide may be considered if diet changes fail and under specialist guidance.

Congenital Epithelial and Transport Disorders

• Microvillus inclusion disease: neonatal onset intractable secretory diarrhea (often high output even when NPO), diagnostic EM features (intracellular microvilli inclusions), often requires long-term parenteral nutrition and consideration for transplant.
• Tufting enteropathy: neonatal severe watery diarrhea with epithelial tufting and villous atrophy; often needs prolonged nutritional support.
• Autoimmune enteropathy and immunodeficiency-associated enteropathies may present with refractory chronic diarrhea and require immunologic and targeted management.

Carbohydrate Malabsorption Disorders

• Lactase deficiency: common, often adult-onset; diagnosis via hydrogen breath testing and managed by dietary lactose reduction and lactase supplements.
• Sucrase-isomaltase deficiency: AR defect causing sucrose/starch intolerance; treat with dietary restriction and sacrosidase enzyme replacement.
• Maltase-glucoamylase, trehalase, fructose transporter, and glucose-galactose malabsorption disorders: each causes characteristic osmotic diarrhea diagnosed by breath testing, biopsy enzyme assays, or genetic testing and managed by dietary modification.

Protein and Amino Acid Transport Defects

• Lysinuric protein intolerance: defective dibasic amino acid transport, failure to thrive, hyperammonemia; managed with protein restriction and citrulline supplementation.
• Enterokinase deficiency: impaired trypsin activation with neonatal diarrhea and hypoproteinemia; managed with pancreatic enzyme replacement.

Fat Malabsorption and Bile Acid Disorders

• Primary bile acid malabsorption (ASBT defect): secretory diarrhea and steatorrhea; may respond to bile acid sequestrants and low-fat diet with MCT supplementation.
• Abetalipoproteinemia: severe steatorrhea, very low serum lipids, fat-soluble vitamin deficiencies; managed with dietary long-chain triglyceride restriction, MCTs and vitamin replacement.
• Exocrine pancreatic insufficiency: cystic fibrosis, chronic pancreatitis or genetic syndromes cause steatorrhea; diagnosis by fecal elastase and treatment with pancreatic enzyme replacement therapy.

Neuroendocrine and Secretory Tumors

VIPomas, gastrinomas, carcinoid tumors and related neuroendocrine lesions cause secretory diarrhea with characteristic biochemical abnormalities and require tumor localization and directed therapy.

Inflammatory and Immune-Mediated Enteropathies

• Inflammatory bowel disease (Crohn disease, ulcerative colitis) presents with chronic inflammatory diarrhea, bleeding, systemic features and growth failure; diagnosis via endoscopy and imaging and managed with anti-inflammatory and immunomodulatory therapies.
• Autoimmune enteropathy and eosinophilic gastroenteritis require biopsy diagnosis and immune-directed treatments.

Infectious Chronic Diarrhea

Persistent parasitic infections (Giardia, Cryptosporidium), chronic C. difficile and HIV-associated enteropathy can cause prolonged diarrhea and require targeted antimicrobial or supportive therapies.

Functional and Overflow Etiologies

Irritable bowel syndrome causes chronic symptoms without structural disease; fecal impaction can produce paradoxical watery stool (overflow) and requires identification and disimpaction.

General Management Principles

• Rapid assessment and correction of dehydration and electrolyte imbalances is the immediate priority in acute diarrhea.
• Oral rehydration solutions for mild-moderate dehydration; intravenous fluids for severe dehydration or shock.
• Continue nutrition and breastfeeding when possible to prevent malnutrition.
• Treat specific causes: targeted antimicrobials for infections, enzyme replacement for disaccharidase deficiencies, pancreatic enzyme replacement for exocrine insufficiency, bile acid sequestrants for bile acid diarrhea when appropriate, and immunomodulation for inflammatory or autoimmune disorders.
• Avoid antimotility agents in suspected invasive bacterial or toxin-mediated colitis and in young children unless recommended by specialists.
• Consider probiotics for prevention of antibiotic-associated diarrhea in children.
• Long-term follow-up for chronic diarrhea should track growth, nutritional status, and directed testing guided by clinical course and initial results.

When to Escalate Care or Perform Advanced Testing

• Red flags: significant weight loss, persistent high-volume diarrhea with dehydration, persistent fever, bloody stools, severe abdominal pain, systemic signs, failure to thrive, abnormal labs (high inflammatory markers, hypoalbuminemia), or abnormal imaging.
• Failure of conservative management, progressive nutritional decline, or suspected complex congenital or inflammatory disorders require endoscopy with biopsies, advanced imaging, specialist consultation and potential referral to intestinal failure or transplant centers.